197 related articles for article (PubMed ID: 9248709)
1. Alternative insulin delivery systems: how demanding should the patient be?
Polonsky KS; Byrne MM; Sturis J
Diabetologia; 1997 Jul; 40 Suppl 2():S97-101. PubMed ID: 9248709
[No Abstract] [Full Text] [Related]
2. Insulin Pumps.
Pickup JC
Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
[No Abstract] [Full Text] [Related]
3. Closing the Loop.
Nimri R; Audon P; Pinsker JE; Dassau E
Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
[No Abstract] [Full Text] [Related]
4. Diabetes Technology and the Human Factor.
Liberman A; Barnard K
Diabetes Technol Ther; 2018 Feb; 20(S1):S128-S138. PubMed ID: 29437474
[No Abstract] [Full Text] [Related]
5. On calculating treatment satisfaction.
Bradley C
Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762
[No Abstract] [Full Text] [Related]
6. Talking Points for Helping Your Type 1 Diabetes Patient Decide About Hybrid Closed Loop.
Perkins BA; Cardinez N; Opsteen CF
Can J Diabetes; 2020 Jun; 44(4):356-358. PubMed ID: 31866241
[No Abstract] [Full Text] [Related]
7. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
8. Continuous subcutaneous insulin infusion--an historical perspective.
Skyler JS
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S5-9. PubMed ID: 20515307
[No Abstract] [Full Text] [Related]
9. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
[TBL] [Abstract][Full Text] [Related]
10. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy.
Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY
J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791
[No Abstract] [Full Text] [Related]
11. Large Treatment Effects With Automated Insulin Delivery System.
Slomski A
JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258
[No Abstract] [Full Text] [Related]
12. Technology and Pregnancy.
Yamamoto JM; Murphy HR
Diabetes Technol Ther; 2018 Feb; 20(S1):S94-S103. PubMed ID: 29437483
[No Abstract] [Full Text] [Related]
13. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
Forlenza GP
Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
[No Abstract] [Full Text] [Related]
14. Pre-dinner walks may be superior to post-dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems.
Turner LV; Riddell MC
Diabetes Obes Metab; 2024 Jun; 26(6):2492-2496. PubMed ID: 38433709
[No Abstract] [Full Text] [Related]
15. Continuous Glucose Monitoring in 2016.
Bode BW; Battelino T
Diabetes Technol Ther; 2017 Feb; 19(S1):S11-S18. PubMed ID: 28192020
[No Abstract] [Full Text] [Related]
16. Severe Hypoglycemia Before Landing in a Patient with Type 1 Diabetes Using Sensor-Augmented Pump Therapy.
Viñals C; Pané A; Quirós C; Giménez M; Conget I
Diabetes Technol Ther; 2017 Aug; 19(8):491-492. PubMed ID: 28594566
[No Abstract] [Full Text] [Related]
17. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View.
Freckmann G; Schlüter S; Heinemann L;
J Diabetes Sci Technol; 2017 Jul; 11(4):653-656. PubMed ID: 28745088
[No Abstract] [Full Text] [Related]
18. Gelling of insulin within an insulin pump reservoir.
Blumer I
Diabet Med; 2008 Sep; 25(9):1131. PubMed ID: 18937680
[No Abstract] [Full Text] [Related]
19. Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes Camps.
Taylor KA; Forlenza GP
Diabetes Technol Ther; 2020 Jul; 22(7):535-537. PubMed ID: 32058821
[No Abstract] [Full Text] [Related]
20. Open-source Closed-Loop System Is Effective for Type 1 Diabetes.
Larkin HD
JAMA; 2022 Oct; 328(14):1387-1388. PubMed ID: 36219416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
